SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Intellipharmaceutics International Inc. (IPCI)

Tilator- These are the only companies with XR approvals...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
wimuskyfisherman Member Profile
 
Followed By 4
Posts 1,030
Boards Moderated 0
Alias Born 11/26/14
160x600 placeholder
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 10/20/2017 5:20:34 PM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 10/18/2017 3:20:22 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/16/2017 6:03:43 AM
Intellipharmaceutics Announces Closing of US$4 Million Financing "GlobeNewswire Inc." - 10/13/2017 5:45:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 10/13/2017 6:04:15 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/12/2017 4:07:48 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/11/2017 8:07:45 AM
Intellipharmaceutics Announces US$4 Million Registered Direct Offering "GlobeNewswire Inc." - 10/11/2017 8:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/10/2017 5:25:56 PM
Intellipharmaceutics Announces Third Quarter 2017 Results "GlobeNewswire Inc." - 10/10/2017 5:20:59 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/25/2017 7:12:00 AM
Intellipharmaceutics Receives Complete Response Letter from the FDA for Rexista™ NDA "GlobeNewswire Inc." - 9/25/2017 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/20/2017 5:18:47 PM
Intellipharmaceutics Announces Receipt of Nasdaq Notice "GlobeNewswire Inc." - 9/20/2017 5:10:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/5/2017 2:43:50 PM
Intellipharmaceutics Provides Operational Update "GlobeNewswire Inc." - 9/5/2017 2:35:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/1/2017 8:10:22 AM
Intellipharmaceutics Appoints New Chief Financial Officer "GlobeNewswire Inc." - 9/1/2017 8:00:00 AM
Monteverde & Associates PC Invites IntelliPharmaCeutics International Inc. Shareholders with Losses in Excess of $1... "PR Newswire (US)" - 8/15/2017 4:52:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/8/2017 3:06:36 PM
Intellipharmaceutics Announces Resignation of Chief Financial Officer "GlobeNewswire Inc." - 8/8/2017 3:00:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 7/31/2017 8:10:21 AM
Intellipharmaceutics Intends to Vigorously Defend Recently Filed Purported Class Action Lawsuit "GlobeNewswire Inc." - 7/31/2017 8:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 7/27/2017 6:07:34 AM
Intellipharmaceutics Provides Update on FDA Advisory Committees Meeting for Rexista™ (oxycodone hydrochloride extended rele... "GlobeNewswire Inc." - 7/26/2017 8:15:00 PM
wimuskyfisherman   Friday, 11/10/17 07:42:50 PM
Re: wimuskyfisherman post# 31217
Post # of 31358 
Tilator- These are the only companies with XR approvals...

QUETIAPINE FUMARATE QUETIAPINE FUMARATE A090681 TABLET, EXTENDED RELEASE ORAL EQ 150MG BASE AB ACCORD HEALTHCARE INC
RX QUETIAPINE FUMARATE QUETIAPINE FUMARATE A202939 TABLET, EXTENDED RELEASE ORAL EQ 150MG BASE AB INTELLIPHARMACEUTICS CORP
RX QUETIAPINE FUMARATE QUETIAPINE FUMARATE A204203 TABLET, EXTENDED RELEASE ORAL EQ 150MG BASE AB LUPIN LTD
RX QUETIAPINE FUMARATE QUETIAPINE FUMARATE A090482 TABLET, EXTENDED RELEASE ORAL EQ 150MG BASE AB PAR PHARMACEUTICAL INC
RX QUETIAPINE FUMARATE QUETIAPINE FUMARATE A206260 TABLET, EXTENDED RELEASE ORAL EQ 150MG BASE AB PHARMADAX INC
RX QUETIAPINE FUMARATE QUETIAPINE FUMARATE A090681 TABLET, EXTENDED RELEASE ORAL EQ 200MG BASE AB ACCORD HEALTHCARE INC


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist